Health · Indianapolis, United States · United States of America · October 29, 2026

Eli Lilly raises outlook on obesity drug sales

Reported by 1 outlet · first reported Oct 29, 8:06 AM ET

Lilly lifted its forecast on demand for obesity drugs.

Why it matters

Signals growing use of weight-loss drugs.

Background

Lilly makes GLP-1 drugs.

Sources

• CNBC ↗Oct 29, 8:06 AM ET

This summary was written automatically from the reporting linked above; follow the sources for the full story. How One Turn works.

See it on the globe →All of Oct 29's stories